Compare CVLT & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVLT | INDV |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.7B |
| IPO Year | 2006 | 2014 |
| Metric | CVLT | INDV |
|---|---|---|
| Price | $148.82 | $35.55 |
| Analyst Decision | Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $139.53 | N/A |
| AVG Volume (30 Days) | 433.6K | ★ 1.5M |
| Earning Date | 04-28-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | 0.50 | ★ 1.67 |
| Revenue | $1,183,690,000.00 | ★ $1,239,000,000.00 |
| Revenue This Year | $13.29 | N/A |
| Revenue Next Year | $13.20 | N/A |
| P/E Ratio | $287.90 | ★ $20.39 |
| Revenue Growth | ★ 18.89 | 4.29 |
| 52 Week Low | $71.75 | $22.22 |
| 52 Week High | $198.18 | $42.81 |
| Indicator | CVLT | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 60.30 | 30.06 |
| Support Level | $115.77 | $33.15 |
| Resistance Level | $152.63 | $35.54 |
| Average True Range (ATR) | 4.57 | 0.81 |
| MACD | 1.40 | 0.02 |
| Stochastic Oscillator | 100.00 | 14.03 |
CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).